Exploring how HIF-1α's survival mechanisms can become pathological when activated by TOR and SMAD pathways in cancer, autoimmunity, and fibrosis.
Groundbreaking research reveals how tumor-derived IGFBP-3 drives muscle wasting in pancreatic cancer patients through metabolic hijacking.
Explore how adenoviruses disrupt the cellular DNA Damage Response (DDR) pathway to enable viral replication, with implications for cancer therapy.
Groundbreaking research on SIAH2 inhibition as a promising approach to contain metastatic spread in treatment-resistant cancers.
Discover how genetically modified switchgrass with elevated miR156 levels produces 250% more biomass while offering natural bioconfinement for sustainable biofuel production.
Discover how A20 (TNFAIP3) genetic variations impact inflammation and autoimmune disease risks in Hispanic populations through groundbreaking research.
Discover how PROTAC technology is revolutionizing cancer therapy by targeting MLK3 in triple-negative breast cancer, offering hope against treatment-resistant tumors.
Discover how silencing the PJA1 enzyme could revolutionize liver cancer treatment by restoring the TGF-β pathway's tumor-suppressing capabilities.
Explore the fascinating world of SUMOylation - a crucial post-translational modification that regulates protein function, cellular organization, and human health.
How the plant-derived molecule UNBS1450 disrupts NF-κB signaling in non-small cell lung cancer cells, overcoming chemotherapy resistance.